State Street’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.9M | Sell |
|
|||||
|
2025
Q1 | $27.4M | Buy |
|
|||||
|
2024
Q4 | $39.1M | Buy |
|
|||||
|
2024
Q3 | $45.3M | Buy |
|
|||||
|
2024
Q2 | $33.1M | Buy |
|
|||||
|
2024
Q1 | $5.1M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $87.9K | Sell |
|
|||||
|
2023
Q1 | $62.3K | Hold |
|
|||||
|
2022
Q4 | $96.7K | Buy |
|
|||||
|
2022
Q3 | $84K | Hold |
|
|||||
|
2022
Q2 | $80K | Sell |
|
|||||
|
2022
Q1 | $1.81M | Buy |
|
|||||
|
2021
Q4 | $3.6M | Sell |
|
|||||
|
2021
Q3 | $6.1M | Buy |
|
|||||
|
2021
Q2 | $5.27M | Buy |
|
|||||
|
2021
Q1 | $5.69M | Sell |
|
|||||
|
2020
Q4 | $5.72M | Buy |
|
|||||
|
2020
Q3 | $4.66M | Buy |
|
|||||
|
2020
Q2 | $6.04M | Buy |
|
|||||
|
2020
Q1 | $2.2M | Buy |
|
|||||
|
2019
Q4 | $3.55M | Buy |
|
|||||
|
2019
Q3 | $3.32M | Buy |
|
|||||
|
2019
Q2 | $2.63M | Buy |
|
|||||
|
2019
Q1 | $1.97M | Sell |
|
|||||
|
2018
Q4 | $1.84M | Sell |
|
|||||
|
2018
Q3 | $2.38M | Buy |
|
|||||
|
2018
Q2 | $2.37M | Buy |
|